Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Discovery|July 25, 2012
Models and screening assays for drug discovery in osteoporosisJukka P Rissanen, Jussi M HalleenCalcified Tissue International|December 18, 2007
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy modelJukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.Journal of Bone and Mineral Metabolism|November 20, 2008
Improved methods for testing antiresorptive compounds in human osteoclast culturesJukka P Rissanen, Hannele Ylipahkala, Katja M Fagerlund, et al.Calcified Tissue International|January 26, 2008
Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy modelJukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.Journal of the National Cancer Institute|May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasisMari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.International Journal of Molecular Sciences|June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse ModelMari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.Molecular Cancer Research : MCR|April 24, 2012
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasisSirkku Pollari, Rami S Käkönen, Khalid S Mohammad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsMari I Suominen, Katja M Fagerlund, Jukka P Rissanen, et al.Pageof 1